Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro

Ophthalmic Research

Volumn 53, Issue 3, 2015, Pages 109-116

  Li, Fangting ^a,b,c   Bai, Yujing ^a,b,c   Zhao, Min ^a,b,c   Huang, Lvzhen ^a,b,c   Li, Shanshan ^a,b,c   Li, Xiaoxin ^a,b,c   Chen, Yi ^a,b,c  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases   (China)

Author keywords

Choroidal and retinal angiogenesis; Quercetin; Rhesus macaque choroid retinal endothelial (RF 6A) cell line; Vascular endothelial growth factor

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; MATRIGEL; QUERCETIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ANGIOGENESIS INHIBITOR; ANTIOXIDANT; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHOROID; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RETINA; RHESUS MONKEY; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL MOTION; CHEMICALLY INDUCED; CHOROIDAL NEOVASCULARIZATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; PATHOLOGY; RETINAL NEOVASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIOXIDANTS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CHOROID; CHOROIDAL NEOVASCULARIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; MACACA MULATTA; QUERCETIN; RETINA; RETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84923077203     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000369824     Document Type: Article

References (29)

1. Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group: Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011; 17; 364: 603-615
2. Aiello LP: Perspectives on diabetic retinopathy. Am J Ophthalmol 2003; 136: 122-135
3. De Jong PT: Age-related macular degeneration. N Engl J Med 2006; 355: 1474-1485
4. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann R: Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003; 22: 1-29
5. Gariano RF, Gardner T: Retinal angiogenesis in development and disease. Nature 2005; 438: 960-966
6. Van Geest RJ, Lesnik-Oberstein SY, Tan HS, Mura M, Goldschmeding R, Van Noorden CJ, Klaassen I, Schlingemann RO: A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol 2012; 96: 587-590
7. Lamson D, Brignall M: Antioxidants and cancer. 3. Quercetin. Altern Med Rev 2000; 5: 196-208
8. Sellappan S, Akoh C: Flavonoids and antioxidant capacity of Georgia-grown Vidalia onions. J Agric Food Chem 2002; 50: 5338-5342
9. Formica JV, Regelson W: Review of the biology of quercetin and related bioflavonoids. Food ChemToxicol 1995; 33: 1061-1080
10. Lee KW, Kim YJ, Kim DO, Lee HJ, Lee CY: Major phenolics in apple and their contribution to the total antioxidant capacity. J Agric Food Chem 2003; 51: 6516-6520
11. Chen Y, Li XX, Xing NZ, Cao XG: Quercetin inhibits choroidal and retinal angiogenesis in vitro. Graefes Arch Clin Exp Ophthalmol 2008; 246: 373-378
12. Perez-Vizcaino F, Duarte J: Flavonols and cardiovascular disease. Mol Aspects Med 2010; 31: 478-494
13. De Boer VC, Dihal AA, van der Woude H, Arts IC, Wolffram S, Alink GM, Rietjens IM, Keijer J, Hollman PC: Tissue distribution of quercetin in rats and pigs. J Nutr 2005; 135: 1718-1725
14. Corvazier E, Maclouf J: Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophilis. Biochim Biophys Acta 1985; 835: 315-321
15. Havesteen B: Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983; 32: 1141-1148
16. Castillo MH, Perkins E, Campbell JH, Doerr R, Hassett JM, Kandaswami C, Middleton E Jr: The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am J Surg 1989; 158: 351-355
17. Rodgers EH, Grant MH: The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF 7. human breast cancer cells. Chem Biol Interact 1998; 116: 213-228
18. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L: Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997; 57: 2916-2921
19. Igura K, Ohta T, Kuroda Y, Kaji K: Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 2001; 171: 11-16
20. Tan WF, Lin LP, Li MH, Zhang YX, Tong YG, Xiao D, Ding J: Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur J Pharmacol 2003; 459: 255-262
21. Oh SJ, Kim O, Lee JS, Kim JA, Kim MR, Choi HS, Shim JH, Kang KW, Kim YC: Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells. Food Chem Toxicol 2010; 48: 3227-3234
22. Zhao D, Qin C, Fan X, Li Y, Gu B: Inhibitory effects of quercetin on angiogenesis in larval zebrafish and human umbilical vein endothelial cells. Eur J Pharmacol 2014; 723: 360-367
23. Rousseau S, Houle F, Huot J: Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. Trends Cardiovasc Med 2000; 10: 321-327
24. Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676
25. Kowanetz M, Ferrara N: Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 2006; 12: 5018-5022
26. Shibuya M: Differential roles of vascular endothelial growth factor receptor-1 and receptor-2. in angiogenesis. J Biochem Mol Biol 2006; 39: 469-478
27. Byrne AM, Bouchier-Hayes DJ, Harmey JH: Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005; 9: 777-794
28. Yu X, Zhu J, Mi M, Chen W, Pan Q, Wei M: Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation. Med Oncol 2012; 29: 349-357
29. Takahashi T, Yamaguchi S, Chida K, Shibuya M: A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLCgamma and DNA synthesis in vascular endothelial cells. EMBO J 2001; 20: 2768-2778